Opus Genetics, Inc. (IRD) Institutional Ownership

Ownership Summary

Opus Genetics, Inc. (NASDAQ:IRD) has 79 institutional investors that have filed 13F reports for the period ending March 2026.

• They owned 52.3% of outstanding stock in March 2026, up from 46.6% the prior quarter.
• Their total shares held in IRD increased 73.67% quarter over quarter, and separately, investors owning Opus Genetics increased 68.09% from a year ago.
• Of these 79 funds, 44 grew their exposure to Opus Genetics, 17 cut back, and 18 maintained positions.
• The aggregate institutional position in Opus Genetics amounted to 45.41Mn shares as of March 2026, up by 19.26Mn shares quarter on quarter, and up 26.22Mn shares year over year.
• As of March 31, 2026, the biggest holder of Opus Genetics is Caligan Partners LP at 6.08Mn shares, representing 6.99% of shares outstanding.
• Leading buyers of Opus Genetics shares for the quarter ending March 2026 were Caligan Partners LP (6.08Mn), ADAGE CAPITAL PARTNERS GP, L.L.C. (4.92Mn), VANGUARD CAPITAL MANAGEMENT LLC (2.45Mn), Boxer Capital Management, LLC (2.25Mn), MARSHALL WACE, LLP (2.16Mn).
• The largest sales of IRD for the quarter ending March 2026 came from Nantahala Capital Management, LLC (3.1Mn), PERCEPTIVE ADVISORS LLC (2.49Mn), Opaleye Management Inc. (1.12Mn), Mink Brook Asset Management LLC (1.08Mn), Wells Fargo & Company/Mn (238.09K).
• According to Business Quant data, leading holders of IRD for March 2026 are Caligan Partners LP (6.08Mn), ADAGE CAPITAL PARTNERS GP, L.L.C. (6.03Mn), BIOS Capital Management, LP (3.68Mn), BALYASNY ASSET MANAGEMENT L.P. (2.72Mn), MILLENNIUM MANAGEMENT LLC (2.63Mn), VANGUARD CAPITAL MANAGEMENT LLC (2.45Mn), MARSHALL WACE, LLP (2.31Mn), Boxer Capital Management, LLC (2.25Mn), ADAR1 Capital Management, LLC (1.85Mn), PERCEPTIVE ADVISORS LLC (1.84Mn).